The pediatric neurotransmitter disorders.

Area of Science:

• Neurology
• Biochemistry
• Genetics

Background:

• Pediatric neurotransmitter disorders are a growing category of neurological conditions.
• These disorders stem from abnormalities in neurotransmitter synthesis and breakdown pathways.
• Key neurotransmitters affected include dopamine, serotonin, glycine, and gamma-aminobutyric acid (GABA).

Purpose of the Study:

• To review and categorize pediatric neurotransmitter disorders.
• To highlight diagnostic challenges and therapeutic strategies.
• To emphasize the importance of specific biochemical analyses for accurate diagnosis.

Main Methods:

• Literature review of pediatric neurotransmitter disorders.
• Analysis of diagnostic criteria and biochemical markers.
• Summary of treatment responses for various conditions.

Main Results:

• Disorders of dopamine and serotonin synthesis include aromatic amino acid decarboxylase deficiency, tyrosine hydroxylase deficiency, and tetrahydrobiopterin synthesis disorders.
• Segawa disease (GTP cyclohydrolase deficiency) shows significant levodopa responsiveness.
• Glycine encephalopathy and GABA metabolism disorders present with diverse neurological symptoms, including seizures and neuropsychiatric issues.

Conclusions:

• Accurate diagnosis of neurotransmitter disorders often requires cerebrospinal fluid analysis, distinguishing them from conditions with elevated phenylalanine.
• Lifelong treatment responsiveness, as seen in Segawa disease, underscores the importance of timely intervention.
• Pyridoxine-dependent seizures have identified new enzymatic deficiencies, expanding treatment options with pyridoxal-5-phosphate.